The Technical Analyst
Select Language :
BriaCell Therapeutics [BCTX]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

BriaCell Therapeutics Price, Forecast, Insider, Ratings, Fundamentals & Signals

BriaCell Therapeutics is listed at the  Exchange

7.12% $2.86

America/New_York / 28 mar 2024 @ 16:00


BriaCell Therapeutics: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 45.71 mill
EPS: -0.790
P/E: -3.62
Earnings Date: Jun 09, 2024
SharesOutstanding: 15.98 mill
Avg Daily Volume: 0.103 mill
RATING 2024-03-28
B-
Sell
RATINGS
Rating CashFlow: Neutral
Return On Equity: Strong Buy
Return On Asset: Strong Sell
DE: Sell
P/E: Sell
Price To Book: Strong Sell
QUARTER GROWTHS
4/221/232/233/234/231/24
Revenuen/an/an/an/an/an/a
Gr.Profitn/a
Ebit
Asset
Debtn/an/an/an/an/a
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -3.62 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-0.62x
Company: PE -3.62 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
$1.005
(-64.86%) $-1.855
Date: 2024-03-29
Expected Trading Range (DAY)

$ 2.57 - 3.15

( +/- 10.24%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2022-12-28 Bondarenko Jamieson Buy 28 000 Common Shares
2022-12-23 Williams William V. Buy 2 530 Warrant
2022-12-20 Bondarenko Jamieson Buy 22 000 Common Shares
2022-08-01 Bondarenko Jamieson Sell 0 Common Shares
2021-03-29 Bondarenko Jamieson Sell 150 000 Option (Right to Buy)
INSIDER POWER
-71.72
Last 25 transactions
Buy: 52 530 | Sell: 1 209 572

Forecast: 16:00 - $2.86

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $2.86
Forecast 2: 16:00 - $2.86
Forecast 3: 16:00 - $2.86
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $2.86 (7.12% )
Volume 0.0872 mill
Avg. Vol. 0.103 mill
% of Avg. Vol 84.32 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for BriaCell Therapeutics Corp.

Last 12 Months

Last 12 months chart data with high, low, open and close for BriaCell Therapeutics Corp.

RSI

Intraday RSI14 chart for BriaCell Therapeutics Corp.

Last 10 Buy & Sell Signals For BCTX

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            BriaCell Therapeutics Corp.

BCTX

BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing immunotherapies for the treatment of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and development agreement with the National Cancer Institute for developing Bria-OTS, a personalized immunotherapy for advanced breast cancer; and BriaDx, a diagnostic test. BriaCell Therapeutics Corp. is headquartered in West Vancouver, Canada.

Last 10 Buy Signals

Date Signal @
TIAUSDMar 29 - 08:3815.02
ETHUPUSDMar 29 - 08:3834.55
MPLUSDMar 29 - 08:3422.12
DCRUSDMar 29 - 08:30$28.20
RBNUSDMar 29 - 08:301.670
GTUSDMar 29 - 08:30$9.91
BORAUSDMar 29 - 08:29$0.227
ATORUSDMar 29 - 08:293.34
IONUSDMar 29 - 08:24451.18
RADUSDMar 29 - 08:24$3.39

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.